A Proposed Suffix Should Be:

Proposed Suffix Should Not:

Be false or misleading , such as by making misrepresentations with respect to safety or efficacy
Include numerals and other symbols aside from the hyphen attaching the suffix to the core name
Include abbreviations commonly used in clinical practice in a manner that may lead the suffix to be misinterpreted as another element on the prescription or order
Contain or suggest any drug substance name or core name
Look similar to or be capable of being mistaken for the name of a currently marketed product
Look similar to or otherwise connote the name of the license holder
Be too similar to any other FDA-designated nonproprietary name suffix

[New provisions in bold italics]

Biologic Product Naming: US FDA Sticks With Suffixes ‘Devoid Of Meaning’

More from Biosimilars